AR008072A1 - Microparticulas de una proteina, complejos formados por dichas microparticulas, usos de dichos complejos, y agente de contraste al ultrasonido - Google Patents

Microparticulas de una proteina, complejos formados por dichas microparticulas, usos de dichos complejos, y agente de contraste al ultrasonido

Info

Publication number
AR008072A1
AR008072A1 ARP970103331A ARP970103331A AR008072A1 AR 008072 A1 AR008072 A1 AR 008072A1 AR P970103331 A ARP970103331 A AR P970103331A AR P970103331 A ARP970103331 A AR P970103331A AR 008072 A1 AR008072 A1 AR 008072A1
Authority
AR
Argentina
Prior art keywords
microparticles
complexes
protein
ultrasound
agent
Prior art date
Application number
ARP970103331A
Other languages
English (en)
Original Assignee
Andaris Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andaris Ltd filed Critical Andaris Ltd
Publication of AR008072A1 publication Critical patent/AR008072A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/225—Microparticles, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Micropartículas de una proteína que es capaz de unir lípidos y micropartículas de una proteína que es capaz de unir lípidos y que tienelípidos no naturales unidos a ella. Además, se dan a conocer complejos de dichas micropartículas, usos de dichos complejos, y un agente de contraste alultrasonido que comprende a dichas micropartículas.
ARP970103331A 1996-07-23 1997-07-23 Microparticulas de una proteina, complejos formados por dichas microparticulas, usos de dichos complejos, y agente de contraste al ultrasonido AR008072A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9615435.6A GB9615435D0 (en) 1996-07-23 1996-07-23 Spray-dried product and its therapeutic use

Publications (1)

Publication Number Publication Date
AR008072A1 true AR008072A1 (es) 1999-12-09

Family

ID=10797357

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970103331A AR008072A1 (es) 1996-07-23 1997-07-23 Microparticulas de una proteina, complejos formados por dichas microparticulas, usos de dichos complejos, y agente de contraste al ultrasonido

Country Status (10)

Country Link
US (2) US6495527B1 (es)
EP (1) EP0918511A2 (es)
JP (1) JP2000514820A (es)
AR (1) AR008072A1 (es)
AU (1) AU720757B2 (es)
CA (1) CA2257524A1 (es)
GB (1) GB9615435D0 (es)
NO (1) NO990303L (es)
WO (1) WO1998003159A2 (es)
ZA (1) ZA976547B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000058734A1 (en) * 1999-03-26 2000-10-05 Martek Biosciences Corporation Specific binding assay for docosahexaenoic acid
AU2005318697A1 (en) * 2004-12-22 2006-06-29 Novozymes A/S Recombinant production of serum albumin
EP1856645A4 (en) * 2005-01-21 2009-12-30 Ischemia Tech Inc TARGETS FOR THE DETECTION OF ISCHEMIA
US20110165649A1 (en) * 2010-01-06 2011-07-07 Brett Tyler Methods and compositions to improve the health of plants, animals and microbes by manipulating protein entry into symbionts and their hosts

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4094965A (en) * 1977-04-01 1978-06-13 New England Nuclear Corporation Diagnostic agents containing albumin and method for making same
US4720385A (en) * 1983-03-29 1988-01-19 Miles Laboratories, Inc. Protein compositions substantially free from infectious agents
US4943527A (en) * 1985-10-04 1990-07-24 California Biotechnology Inc. Mature apoai protein production under serum free culturing conditions
US5725804A (en) * 1991-01-15 1998-03-10 Hemosphere, Inc. Non-crosslinked protein particles for therapeutic and diagnostic use
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
US5981206A (en) * 1992-05-20 1999-11-09 Johnson & Johnson Clinical Diagnostic Systems, Inc. Dry analytical element and method for the detection of prostatic acid phosphatase
US5567415A (en) * 1993-05-12 1996-10-22 The Board Of Regents Of The University Of Nebraska Ultrasound contrast agents and methods for their manufacture and use
BR9509171A (pt) * 1994-09-29 1997-09-16 Andaris Ltd Microparticulas secas por borrifamento como veículos terapêuticos
ES2191721T3 (es) * 1994-12-16 2003-09-16 Elan Drug Delivery Ltd Microparticulas reticuladas y su utilizacion como vehiculos terapeuticos.
DE19651886A1 (de) * 1996-12-13 1998-06-18 Merck Patent Gmbh Mittel und Verfahren zur Bestimmung von hydrolytischen Enzymen
US6352835B1 (en) * 1998-11-17 2002-03-05 Kyoto Daiichi Kagaku Co. Ltd. Method of measuring substance in sample using a redox reaction

Also Published As

Publication number Publication date
AU3628697A (en) 1998-02-10
US20030170177A1 (en) 2003-09-11
CA2257524A1 (en) 1998-01-29
AU720757B2 (en) 2000-06-08
NO990303L (no) 1999-03-22
EP0918511A2 (en) 1999-06-02
GB9615435D0 (en) 1996-09-04
WO1998003159A3 (en) 1998-05-07
NO990303D0 (no) 1999-01-22
ZA976547B (en) 1998-07-23
WO1998003159A2 (en) 1998-01-29
US6495527B1 (en) 2002-12-17
JP2000514820A (ja) 2000-11-07

Similar Documents

Publication Publication Date Title
DK1032662T3 (da) Fremgangsmåder og sammensætninger til immunmodulation
NL300195I2 (nl) Synergistische combinaties van zidovudine, 1592U89en 3TC of FTC.
ES2140076T3 (es) Vacunas que contienen una saponina y un esterol.
ATE354351T1 (de) Alginatgele mit verzögerter freisetzung
BR9801355B1 (pt) emulsço àleo-em-Água, composiÇço cosmÉtica de uso tàpico, utilizaÇço de uma emulsço, processo de tratamento nço terapÊutico da pele e processo de preparaÇço de uma emulsço.
EE200000279A (et) Ravimi nahka penetreerumist suurendavad komponendid
IS2505B (is) Speglunarskuggaefni, sem helst lengi í blóði, til sjúkdómsgreininga
PT989846E (pt) Composicoes cosmeticas e farmaceuticas nao irritantes
BR0202277A (pt) Porta-limpador sólido
ES2216055T3 (es) Metodos para reducir o mantener niveles reducidos de lipidos en sangre usando composiciones de proteina ob.
DK1165537T3 (da) Hydroxymatairesinol til forebyggelse af cancer
ATE206871T1 (de) Molkeprotein/polysaccharide gel, hergestellt durch hochdruckbehandlung
AR008072A1 (es) Microparticulas de una proteina, complejos formados por dichas microparticulas, usos de dichos complejos, y agente de contraste al ultrasonido
PT906529E (pt) Pino de activacao
ES2148127T1 (es) Nueva salchicha cocida y procedimiento para su fabricacion.
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
DE59501224D1 (de) Bremskraftverstärker
ES2146013T3 (es) Champues suaves para el cabello.
DE69511737T2 (de) Verbesserung des virtuellen Realitätseffekts durch Einsatz von Duftstoffen
NL1000990C2 (nl) Gebitsorgaan.
NZ511034A (en) Methods of downmodulating the immune response to therapeutic proteins
FI974532A (fi) Dynaaminen sanomarajapinta
GT199900076A (es) Composicion y metodo.
PT854727E (pt) Antigenios de rejeicao tumoral apresentados pelas moleculas b44-alh e suas utilizacoes
ATE283358T1 (de) Protease-ähnliches protein